The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. The authorization was confirmed by digital health tech company ...

Scientists have developed a new AI model to identify which cancer patients would respond best to a targeted drug on the NHS. Bevacizumab was approved in December for treating advanced bowel cancer on ...

Routine mammograms are the mainstay of breast cancer screening. But, with a new type of analysis powered by artificial intelligence, doctors may be able to also predict whether or not you'll develop ...

Dr. Regina Barzilay’s world turned upside down when she was diagnosed with breast cancer in 2014. It seemed to come out of nowhere. She didn’t know anyone in her family who had BRCA genes — the genes ...

Scientists have developed a new AI model, PhenMap, to identify which advanced bowel cancer patients would best respond to the targeted drug bevacizumab. Bevacizumab, approved for advanced bowel cancer ...